Navigation Links
LSUHSC research shows fish oil protects against diseases like Parkinson's
Date:4/19/2009

New Orleans, LA Dr. Nicolas Bazan, Director of the Neuroscience Center of Excellence, Boyd Professor, and Ernest C. and Yvette C. Villere Chair of Retinal Degenerative Diseases Research at LSU Health Sciences Center New Orleans, will present new research findings showing that an omega three fatty acid in the diet protects brain cells by preventing the misfolding of a protein resulting from a gene mutation in neurodegenerative diseases like Parkinson's and Huntington's. He will present these findings for the first time on Sunday, April 19, 2009 at 10:30 a.m. at the Ernest N. Morial Convention Center, Nouvelle C Room, at the American Society for Nutrition, Experimental Biology 2009 Annual Meeting.

With funding from the National Eye Institute of the National Institutes of Health, Dr. Bazan and his colleagues developed a cell model with a mutation of the Ataxin-1 gene. The defective Ataxin-1 gene induces the misfolding of the protein produced by the gene. These misshapened proteins cannot be properly processed by the cell machinery, resulting in tangled clumps of toxic protein that eventually kill the cell. Spinocerebellar Ataxia, a disabling disorder that affects speech, eye movement, and hand coordination at early ages of life, is one disorder resulting from the Ataxin-1 misfolding defect. The research team led by Dr. Bazan found that the omega three fatty acid, docosahexaenoic acid (DHA), protects cells from this defect.

Dr. Bazan's laboratory discovered earlier that neuroprotectin D1 (NPD1), a naturally-occurring molecule in the human brain that is derived from DHA also promotes brain cell survival. In this system NPD1 is capable of rescue the dying cells with the pathological type of Ataxin-1, keeping their integrity intact.

"These experiments provide proof of principle that neuroprotectin D1 can be applied therapeutically to combat various neurodegenerative diseases," says Dr. Bazan. "Furthermore, this study provides the basis of new t
'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-452-9166
Louisiana State University Health Sciences Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. LSUHSC research may benefit diabetes by increasing understanding of how to control islet cell growth
2. LSUHSCs England leads development of new testing guidelines for common nerve disorder
3. LSUHSCs Dr. Xiao Cheng Wu co-authors annual report to the nation on cancer
4. LSUHSCs Fontham makes history
5. LSUHSC public health contributes to estimate of HPV-related cancers
6. LSUHSC awarded grant to address nursing shortage
7. LSUHSC study finds high-dose HBO2 therapy extends survival window after cardiopulmonary arrest
8. LSUHSC inventor awarded patent for new procedure to detect cancer spread
9. LSUHSC dental school to be awarded top national honor
10. Autism Science Foundation Launches Operations; New Advocacy Group Will Focus on Non-vaccine-related Autism Research
11. Research Takes Aim at Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... Consolidated Access to Interdisciplinary Evidence-based Content throughout the Clinical ... ... (PRWEB) December 7, 2009 -- Institutions currently using point-of-care ... Zynx Health will benefit from a new ... evidence-based resources, resulting in quicker retrieval of relevant and ...
(Date:12/7/2009)... free tax calculator. Answer simple questions about income and watch the tax ... ... return by using the free tax calculator. , , , , ,The calculator ... or worrying about how much the return will be or how much tax ... Find out right now with a few clicks of the mouse. , ...
(Date:12/7/2009)... Dec. 7 Cell Therapeutics, Inc. ("CTI") ... Pettengell, M.D. of St. George,s Hospital, University of ... Society of Hematology ("ASH") Annual Meeting updated results ... clinical trial of pixantrone (the "PIX 301 EXTEND ... ("NHL") patients who have failed 2 or ...
(Date:12/7/2009)... be able to reverse some of the damage to ... down their cigarettes, according to research out of the ... research is published in the December 15 issue of ... and Critical Care Medicine . , "We found that ... of the epithelium, or lining, of the airways in ...
(Date:12/6/2009)... Antonio Bay ,, SILVER SPRING, Md., Dec. 6 ... advising consumers to avoid eating oysters harvested from the ... to reports of norovirus-associated illnesses in some people who ... located on the Gulf of Texas. ,, (Logo: ... with the Centers for Disease Control and Prevention (CDC) ...
Breaking Medicine News(10 mins):Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 2Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 3Health News:2009 Free Tax Return Calculator 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 3Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 4Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 5Health News:Quitting smoking can reverse asthma-inducing changes in lungs 2Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2
... for fat people and inventors. ,Scientists have always sought ... are no exception. //Currently, two thirds of the population can be ... put a morbidly obese figure of 2.2 million pounds ... ,Bloom’s quest is to create a chewing gum or nasal ...
... Eating too much of unhealthy trans fats present in many ... ,Scientists at the Harvard School of Public Health found ... trans fats than fertile women, reported the online edition of ... fat that is formed when vegetable oils are hardened into ...
... A new study reveals the full extent of psychological problems ... About half of those surveyed showed signs of clinical depression, ... findings may not be surprising, specialists are calling them a ... resources to mental healing. ,'In addition to ...
... called nestin to a particularly deadly form of breast ... earlier detection and better treatment.// ,In the January ... School demonstrate that nestin could represent a selective biological ... cancer with similarities to mammary stem cells, the regenerative ...
... the pubic bone as a source of bone for grafting ... crest, or 'hip bone,' according to a report in the ... further study, the pubic bone could become the new standard ... write Dr. John W. Polley and colleagues of Rush University ...
... very word ‘bird flu’ sets them in jitters, take a ... presence of avian influenza or bird flu, //in a Japanese ... birds have died from the disease at a farm situated ... Fisheries Ministry have confirmed the cause of the chicken death ...
Other Medicine News:Health News:Chew That Fat Away 2Health News:Burn Patients Need More Help Coping With Depression 2Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 2Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 3Health News:New Technique Uses Pubic Bone for Grafting 2
(Date:12/4/2009)... 4 AstraZeneca (NYSE: AZN ) today ... has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release ... with Major Depressive Disorder (MDD). SEROQUEL XR is the ... to treat both major depressive disorder as adjunctive therapy ...
(Date:12/3/2009)... , a leading primary research firm, today announced the launch ... that monitors and projects trends and market share in the ... captures actual patient usage for 87 different Sleep Apnea mask ... providers going back to January 2006. In the most ...
(Date:12/3/2009)... and STATE COLLEGE, Pa., Dec. 3 Ambry ... an agreement to provide extended bioinformatics genomics services ... performed at Ambry. ,, (Logo: ... CSO said, "Our team at Ambry has been ...
Breaking Medicine Technology:US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 1Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 2Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 3Sinovac to Present at 2009 UBS Global Life Sciences Conference 14092 1Sinovac to Present at 2009 UBS Global Life Sciences Conference 14092 2How to reach proficiency in laparoscopic splenectomy 3F 57347 1
... plans initiation of clinical studies; Data to be ... 21 Drug discovery and development company Esperance ... preclinical program that support the initiation of ... candidate from the Company,s Cationic Lytic Peptide (CLYP(TM)) ...
... NanoVibronix, a medical device,company specializing in applications ... novel device has received CE approval in ... is the first hands-free,patch-based device that uses ... The innovative PainShield consists of a disposable ...
Other Medicine Technology:First Candidate from Esperance's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept 2First Candidate from Esperance's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept 3NanoVibronix Receives Wound Healing Indications in Europe for its PainShield(TM) Device 2
... USIOL lenses are manufactured using ... processes. Perspex CQ UV PMMA ... multi-piece and single piece lenses. ... in both nonphaco and phaco ...
Optical implants for the replacement of the human crystalline lens in the visual correction of aphakia....
1% Sodium Hyaluronate, 10mg/mL, sterile opthalmic injection...
... with optimum molecular weight and viscosity, so ... coats and protects the delicate structures of ... balance of cohesion, adhesion, and pseudoplasticity to ... phaco surgeon expects from an ophthalmic viscoelastic ...
Medicine Products: